Activity of GH/IGF-1 axis in burn patients: Comparison with normal subjects and patients with GH deficiency

Journal of Endocrinological Investigation

Volumn 25, Issue 2, 2002, Pages 116-124

  Gianotti, L ^a   Stella, M ^b   Bollero, D ^b   Broglio, F ^a   Lanfranco, F ^a   Aimaretti, G ^a   Destefanis, S ^a   Casati, M ^c   Magliacani, G ^b   Ghigo, Ezio ^a  

^a UNIVERSITY OF TURIN   (Italy)

^b CTO HOSPITAL   (Italy)

^c PFIZER INC   (United States)

Author keywords

Burn; Critical illness; Growth hormone; IGF I

Indexed keywords

ALBUMIN; GROWTH HORMONE; GROWTH HORMONE BINDING PROTEIN; PREALBUMIN; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN C; TRANSFERRIN;

ADULT; AGED; ARTICLE; BODY MASS; BURN; CLINICAL OBSERVATION; COMPARATIVE STUDY; CONTROLLED STUDY; CRITICAL ILLNESS; DISEASE ASSOCIATION; DISEASE SEVERITY; FEMALE; GROWTH HORMONE DEFICIENCY; HORMONE ACTION; HORMONE DETERMINATION; HOSPITAL ADMISSION; HUMAN; HYPOPITUITARISM; INTENSIVE CARE UNIT; MAJOR CLINICAL STUDY; MALE; NUTRITIONAL PARAMETERS; PROSPECTIVE STUDY; REBOUND; REHYDRATION; SKIN SURFACE; THERMAL INJURY; TOTAL PARENTERAL NUTRITION;

ADULT; AGED; BACTERIAL INFECTIONS; BODY MASS INDEX; BURNS; FEMALE; HUMAN GROWTH HORMONE; HUMANS; HYPOPITUITARISM; INSULIN-LIKE GROWTH FACTOR BINDING PROTEIN 3; INSULIN-LIKE GROWTH FACTOR I; INTENSIVE CARE; KINETICS; MALE; MIDDLE AGED; NUTRITIONAL STATUS; PREALBUMIN; PROSPECTIVE STUDIES; SERUM ALBUMIN;

EID: 0036119880     PISSN: 03914097     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF03343974     Document Type: Article

References (56)

1. The endocrinology of the critically ill
2. Anterior pituitary function during critical illness and dopamine treatment
3. Pituitary-thyroid axis in critical illness
4. Acquired growth hormone resistance
5. Growth hormone secretion in critical illness: Effects of dopamine
6. Critically ill patients have high basal growth hormone levels with attenuated oscillatory activity associated with low levels of insulin-like growth factor-I
7. The differential regulation of the circulating levels of the insulin-like growth factors and their binding protein (IGFBP) 1, 2 and 3 after elective abdominal surgery
8. Critical illness is associated with low circulating concentrations of insulin-like growth factors-I and II, alterations in insulin-like binding proteins, and induction of an insulin-like growth factor binding protein 3 protease
9. Plasma levels of insulin-like growth factor binding protein-3 in acute trauma patients
10. Nutritional regulation of insulin-like growth factors
11. Somatomedin activity in disorders of nutrition and metabolism
12. Levels of GH binding activity, IGFBP-1, insulin, blood glucose and cortisol in intensive care patients
13. Distributed anabolic hormonal patterns in burned patients: The relation to glucagon
14. Effects of recombinant human growth hormone on donor site healing in severely burned children
15. Recombinant human growth hormone enhances the metabolic efficacy of parenteral nutrition: A double-blind, randomized controlled study
16. Effects of recombinant human growth hormone in patients with severe sepsis
17. Effect of recombinant human growth hormone on catabolic hormones and free fatty acids following thermal injury
18. Effects of human growth hormone on the catabolic state after surgical trauma
19. Increased mortality associated with growth hormone treatment in critically ill adults
20. Biosynthetic human growth hormone in burned patients: A pilot study
21. Wasting in the acquired immune deficiency syndrome is associated with multiple defects in the serum insulin-like growth factor system
22. Growth hormone and cortisol secretion in patients with burn injury
23. Pulsatile nature of growth hormone levels in critical ill trauma victims
24. Circadian growth hormone secretion in asymptomatic human immune deficiency virus infection and acquired immunodeficiency syndrome
25. Low IGF-I levels are often uncoupled with elevated GH levels in catabolic conditions
26. Physiology of growth hormone secretion and action
27. Growth hormone releasing hormone
28. Growth hormone-releasing peptides
29. Peptidomimetic regulation of growth hormone secretion
30. The somatotropic axis in critical illness: Effect of continuous growth hormone (GH)-releasing hormone and GH-releasing peptide-2 infusion
31. Insulin-like growth factor-I blood levels in severely burned patients: Effects of time post injury, age of patient and severity of burn
32. Regulation of the acid-labile subunit of the insulin-like growth factor ternary complex in patients with insulin-dependent diabetes mellitus and severe burns
33. Time course and variability of the endocrine and metabolic response to severe sepsis
34. Two new burn severity indices
35. A specific growth hormone-binding protein in human plasma: Initial characterization
36. Insulin-like growth factor bioactivity and its modification in growth hormone resistant states
37. Biosynthetic human growth hormone in burned patients: A pilot study
38. Hormonal control of metabolism in trauma and sepsis
39. Insulin-like growth factor-I production is inhibited in human sepsis
40. Cytokines and endocrine function: An interaction between the immune and neuroendocrine systems
41. Insulin-like growth factors and their binding proteins: Biological actions
42. Diagnosis of growth hormone deficiency in adults
43. New approach to the diagnosis of growth hormone deficiency in adults
44. Supplementary essential amino acids augment the somatomedin-C/insulin-like growth factor-I response to refeeding after fasting
45. Circulating growth hormone binding proteins
46. Transport proteins as indices of protein status
47. Measurement of prealbumin as index of protein-calorie malnutrition
48. Variations in nutritional parameters after thermal injury in man
49. New modalities for understanding dynamic regulation of the somatotropic (GH) axis: Explication of gender differences in GH neuroregulation in the human
50. Hormonal regulation of human protein metabolism
51. Growth hormone and IGF-I therapy in the hypercatabolic patient
52. Metabolic and therapeutic effects of insulin-like growth factor-I
53. Low concentrations of insulin-like growth factor-I in abdominal obesity
54. The hypothalamic-pituitary-adrenal axis in obese women with different patterns of body fat distribution
55. The impact of gonadal steroid hormone action on growth hormone secretion during childhood and adolescence
56. Contrasting effects of oral and transdermal routes of estrogen replacement therapy on 24-hour growth hormone (GH) secretion, insulin-like growth factor-I, and GH-binding protein in postmenopausal women